In the 36 years since Felty (1924) described a clinical syndrome of 'chronic arthritis in the adult, associated with splenomegaly and leucopenia', a number of individual cases and a few series of patients have been described, but some fundamental questions remain unanswered.
With isolated exceptions (Denko and Zumpft, 1962) , most authors agree that Felty's syndrome is not merely a variant of systemic lupus erythematosus (SLE) or a coincidence of arthritis with some unassociated disease. However, there is little unanimity as to its aetiology and pathology, its relationship to the various manifestations of rheumatoid disease, the range of clinical and haematological manifestations that may occur, and, most important for the individual patient, how the disease should be treated.
Material and methods

SELECTION OF PATIENTS
The diagnosis was accepted when the patient presented with features of 'classical or definite' rheumatoid arthritis (RA) (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) , splenic enlargement without other demonstrable cause, and leucopenia with a total white cell count of less than 3,500 per cu. mm. and a neutrophil count of 2,000 per cu. mm. or less.
IMMUNOLOGY
Latex tests were performed by a modification of the method of Singer and Plotz (1956) . Waaler-Rose tests and subsequently differential sheep cell agglutination titres were performed by modifications of the method of Ball (1950) . Tests for antinuclear factor (ANF), white cell ANF, and salivary gland antibody were performed by immunofluorescence (Roitt and Doniach, 1966) .
Serum white cell antibodies were sought by the complement-fixation technique of van Rood, van Leeuwen, and Eernisse (1959) . Platelet antibodies were sought by agglutination, indirect antiglobulin consumption, and complement fixation, by the methods of van de Wiel, van de Wiel-Dorfmeyer, and van Loghem (1961) and Aster, Cooper, and Singer (1964) .
HAEMATOLOGY
Routine haematological measurements were performed by standard techniques (Dacie and Lewis, 1968) . For the determination of their survival, red cells from the patient were labelled with 56Cr by the method of Mollison and Veall (1955) . The first (100 per cent. activity) blood sample was drawn after initial equilibration of labelled cells in the spleen as determined by counting in vivo over the organ. The normal range in our laboratory for 50 per cent. disappearance of activity is 23 to 29 days. The accumulation of excess counts over the liver and spleen was calculated by the method of Hughes Jones and Szur (1957) ; in normal subjects the excess counts at 50 per cent. disappearance of activity in the blood do not exced 250 for the spleen and 150 for the liver.
HISTOLOGY OF THE SPLEEN 51. sections of paraffin-embedded formol-fixed material from the available spleens from patients with Felty's syndrome ('Felty spleens') were stained with haematoxylin and eosin, Gomori's reticulin, elastic Van Gieson, Perls' iron stain, and congo red.
For comparison, sections were also prepared from 22 spleens weighing less than 300 g. from patients with RA coming to autopsy ('RA control spleens') The exclusion of control spleens weighing more than 300 g. was necessary, since in many of these spleens the presence of amyloid, infection, or malignancy obscured other structural changes.
Results
CLINICAL MATERIAL
21 patients (6 men and 15 women) satisfied the criteria for the diagnosis of Felty's syndrome. The clinical and pathological findings are summarized in Table I (oveileaf). Of the three patients reoeiving phenylbutazone up to the time of diagnosis, one (Case 15) subsequently responded haematologically to splenectomy, one (Case 10) improved spontaneously 6 months later, and one (Case 16) improved spontaneously slowly. None of the patients who stopped taking phenylbutazone between 1 and 2 years before the diagnosis of Felty's syndrome showed any spontaneous improvement in the blood count (Cases 6, 12, 18, 20) .
Gold salts
Seven of the 21 patients had received short courses of injections of sodium aurothiomalate. In no case were these injections given immediately before the development of Felty's syndrome, and in none was there any abnormality in the blood count during chrysotherapy.
Corticosteroids
Eight of the 21 patients (Cases 1, 4, 6, (8) (9) (10) (11) (12) were receiving corticosteroids at the time of development FEATURES OF FELTY' S SYNDROME Onset In ten patients, routine examination revealed either leucopenia or splenic enlargement in the absence of relevant symptoms. Six patients presented with infection, two with haemolytic anaemia, and two with skin ulceration. One patient was diagnosed at autopsy.
The time relationship between the detection of splenic enlargement and the development of neutropenia was variable. The priority of leucopenia (7 patients: up to 4 years) or splenic enlargement (3 patients: up to 3 years) was not related to any other feature of the illness ( Table I) . As in other series (Collier and Brush, 1966; Ruderman, Miller, and Pinals, 1968) there was no correlation between the size of the spleen and the degree ofhaematological abnormality.
On review of the clinical features of their illness before treatment the patients appeared to fall into three groups:
1. SEVERE The nine patients (5 women; 4 men) in this group had neutrophil counts frequently below 500 per cu. mm. and a variety of infections. Four patients also had haemolytic anaemia (Cases [4] [5] [6] 8 The clinical and serological features of the arthritis, and the relationship between the onset of leucopenia and clinical enlargement of the spleen did not differ in the three groups (Table I) .
Splenic enlargement
The spleen was palpable in nineteen of the 21 patients. In one grossly obese patient the spleen could not be palpated with certainty, but was shown to be considerably enlarged by plain x ray and by scintiscanning after the administration of heated 51Cr-labelled red cells. In the last severely crippled patient, an enlarged spleen (588 g.) was discovered only at autopsy. (Table I) . Purpura Four patients developed bruising or purpura. Three were thrombocytopenic, two of whom were receiving corticosteroids. The fourth had a normal platelet count and was not receiving corticosteroids.
Liver
Severe haematemesis in one patient (Case 9) suggested the presence of portal hypertension and this was confirmed at laparotomy. Percutaneous (2) and operative hepatic biopsies showed some portal fibrosis without the changes characteristic of cirrhosis.
Clinical features of liver disease were not seen in any other patient. Flocculation tests were often abnormal in the presence of hyperglobulinaemia. A mild unexplained increase in serum alkaline phosphatase was noted in one, patient (Case 2).
HAEMATOLOGY
Peripheral blood Red cells (Fig. 1, overleaf) . All patients were anaemic (haemoglobin less than 13-5 g./100 ml. in men and less than 12 g./100 ml. in women) but this was severe (less than 8 g./100 ml.) in only one man and two women. The mean corpuscular haemoglobin concentration was less than 30 per cent. in five of the 21 patients, in only three of whom was the blood film considered to be hypochromic. The red cells were normochromic in all other patients, including six in whom polychromasia was present; two showed macrocytosis (Cases 5 and 8). Leucocytes. The lowest total white cell, lowest neutrophil, and highest lymphocyte counts recorded are shown in Fig. 1 (before splenectomy when this was performed). The lymphocyte count usually exceeded the neutrophil count in 17 of the 21 patients. In 5 patients neutropenia was noted before the total white cell count fell below 3,500 per cu. mm; in these cases there was a mild lymphocytosis ofbetween 2,300 and 4,400 per cu. mm.
Platelets (Fig. 1 ). Counts were performed in eighteen patients. Thrombocytopenia (less than 150,000 per cu. mm) was present in ten, but in only four was the count less than 50,000 per cu. mm. Erythrocyte sedimentation rate At the time of diagnosis of Felty's syndrome (Fig. 2) , this did not correlate with the clinical assessment of inflammatory joint activity. Bone marrow Smears were available for re-examination in nineteen cases. Repeated aspiration in one patient produced peripheral blood only (Case 19). The findings are summarized in Table III . Oocasional maoronormoblasts and transitional megaloblasts were seen in four patients with haemolytic anaemia, in none of whom was there evidence of vitamin B12 or folate deficiency. In only one patient was leucopoiesis apparently depressed (Case 1). Mature granulocytes were deficient in the presence of plentiful precursors in thirteen patients, but in six patients mature granulocytes were plentiful in the marrow sample.
Smears stained for iron were available in eleven patients. Reticuloendothelial haemosiderin was increased in three, who were all found to have haemolytic anaemia; it was normal in two and much reduced or absent in seven.
Plasma iron
This was low in all of the ten patients tested, with a diminished total iron-binding capacity (TIBC) in six. The TIBC was elevated in two patients: in one no marrow could be obtained, and in the other, and in four patients in whom the TIBC was not performed, marrow storage iron was grossly diminished or absent.
Haemolytic anaemia (Fig. 3, opposite) Red cell survival was reduced in six of thirteen * patients studied. In vivo counting in these six patients showed an initial sequestration of labelled cells in the spleen in four (spleen : heart ratio after equilibration> 1 -0). In three there was subsequently a significant accumulation of excess counts over the * spleen, indicating splenic destruction of labelled cells. In one there was also a significant increase in excess counts over the liver. S: H ratio To = Spleen: Heart ratio at time zero. in whom red cell survival was not measured. In this man (Case 3) the haemoglobin was 12-5 g./100 ml. with 5 per cent. reticulocytes; the direct antiglobulin reaction was positive, the red cells being sensitized with cold anti-I.
White cell andplatelet antibodies These were present in only one out of four patients tested.
Treatment after diagnosis The outline of treatment received is summarized in Table IV. SYSTEMIC CORTICOSTEROIDS (Table V, overleaf) L Severe group Eight (Cases 1, 3-9) of the nine patients with severe disease were treated with oral corticosteroids. In the six (Cases 3-5, 7-9) who were given prednisolone 20 mg./day or more for at least one month (of whom five were previously receiving 10 mg./day or less for arthritis), there were two (Cases 4, 7) who showed temporary haematological and clinical remission lasting 11 and 8 months respectively, after which both relapsed and died. None of the other four patients remitted and all underwent splenectomy (see below). Neither of the two patients (Cases 1, 6) given less than 20 mg./day prednisolone remitted, and both later proceeded to splenectomy.
IL Moderate group
One patient (Case 11), in whom steroids were increased from 10 to 20 mg./day prednisone and continued for 6 months before dose reduction, underwent complete, apparently permanent, clinical and haematological remission (follow-up now 7 years). Haematological remission occurred apparently spontaneously in one patient (Case 10) who continued to receive the same small dose of prednisone (7 * 5 mg./day) which had been started 7 years before the decline in her white cell count.
III. Mild group
Only one patient (Case 17) in this group received corticosteroids. This was in high dosage and unfortunately no record exists offurther blood counts during this period. He died suddenly from bronchopneumonia.
Two of the remaining six patients in this group, who have not received steroids since the diagnosis of Felty's syndrome, have had spontaneous haematological remissions (Cases 16, 18). Thus, in the whole series, remissions were seen in three of eight patients given at least 20 mg./day prednisone for a minimum of one month, but only one of these did not relapse. Of those given less than 20 mg./day prednisone, only one patient, receiving 7 -5 mg./day, underwent partial remission.
There were also two spontaneous haematological remissions in the nine patients not treated with corticosteroids, in one of whom the spleen became impalpable.
SURGICAL TREATMENT-SPLENECTOMY
The indications for operation and its effect in the ten patients submitted to splenectomy are shown in Table VI .
The immediate good effect of splenectomy seen in eight of the ten patients was maintained in only three patients, but one of them (Case 5) died 4 months after operation, probably from infection (no autopsy), without any deterioration in his white cell count. The other two patients (Cases 2, 15) have continued to have a completely normal blood picture 14* and 6 years respectively after splenectomy. A complete and spontaneous remission eventually occurred in one of the five patients who relapsed (Case 1). Three other patients died: one shortly after operation, one 15 months after operation of unknown cause (no autopsy), and one 15 months after operation in renal failure. Felty spleens in which erythrophagocytosis was most marked. Excess iron was also seen in a similar proportion of the RA control spleens. In all but one of the Felty spleens, and in all the RA control spleens, varying amounts of birefringent particulate material were present in the cytoplasm of the sinusoidal macrophages. This had the characteristics of formalin pigment, since it disappeared after exposure to picric acid and did not stain for iron. After treatment with picric acid the cytoplasm of these cells was seen to contain ill-defined colourless inclusions. This birefringent particulate material was not found in spleens from 25 patients without rheumatoid disease.
In the splenic cords increased reticulin formation and reticulum cell hyperplasia were found more often in the Felty spleens than in the RA control spleens. In all Felty spleens plasma cells were increased and there were scattered foci of megakaryocytes and myeloid cells indicating extramedullary haemopoiesis. In only three RA control spleens was there any extra-medullary haemopoiesis.
(2) LIVER Histological examination of the liver in the five cases which came to autopsy (Nos 4, 7, 8, 17 , and 21) and in the one patient who had liver biopsies (No. 9) revealed no evidence of cirrhosis or amyloidosis. Discussion Some authors have doubted the specific entity of Felty's syndrome. In this series there was no evidence of another cause of splenic enlargement, e.g. lymphoma or cirrhosis, and no patient diagnosed as Felty's syndrome had later to be excluded because of the discovery of another disease or of splenic amyloidosis. We have seen one patient with seronegative psoriatic arthropathy and leucopenia, whose splenic enlargement was found at operation to be due to lymphosarooma, but we have been unable to find a single case of 'idiopathic' splenomegaly and leucopenia in degenerative joint disease, nor has splenectomy been performed in any such patient in The London Hospital over the last 12 years. The clinical features of the patients under review provide further evidence for the existence of a specific syndrome, and the pathological material from splenectomies and autopsies supports this view.
While leucopenia is one of the accepted criteria for the diagnosis, five of our patients showed neutropenia with a normal total white count in the early stages of their haematological illness, and therefore it would be preferable to specify neutropenia in the definition of the syndrome. While Felty's syndrome has been considered to develop mainly in the elderly (de Gruchy, 1965) , one-third of our patients were under 60 years. The men were significantly older than the women at the onset of arthritis, but developed Felty's syndrome far earlier in the course of their illness. This was not related to any obvious sex differences in the character of their rheumatoid disease.
Rheumatoid nodules and Sj0gren's syndrome were both common in our patients, but other nonarticular manifestations of rheumatoid disease were not unduly frequent. No patient showed a skin rash, inflammation of serous surfaces or myocarditis, or any other features suggestive of SLE. One patient had moderate renal failure, but the renal biopsy showed chronic glomerulonephritis.
As in other series (Ruderman and others, 1968) , most of our patients had positive tests for rheumatoid factor, often in high titre. Two patients had negative latex tests but were considered to have undoubted rheumatoid arthritis because in each the joint involvement was typical with erosive radiological changes. (Willkens and Decker, 1963) . The absence of histological features of SLE in the thirteen spleens examined makes it extremely unlikely that Felty's syndrome is a manifestation of this disease as suggested by Denko and Zumpft (1962) .
The nonarticular clinical features in our patients were much the same as previously described (de Gruchy, 1965; Ruderman and others, 1968 (Willkens and Decker, 1963) .
Every patient was anaemic. Haemolysis appeared to be the major factor in the three patients wvith severe anaemia, and was also found in three others.
In two of these six shortened red cell survival was probably due to sensitization by immune antibodies (positive direct antiglobulin test). Destruction of red cells by the spleen appeared to be the cause in three, in whom together with the sixth patient the 51Cr study also revealed significant pooling (sequestration) of red oells in the organ. However, pooling by itself cannot account for haemolysis in this sixth patient because it was also found in four patients with a normal red cell survival. While haemolytic anaemia in Felty's syndrome has been attributed to the direct action of the large spleen (Hume, Dagg, Fraser, and Goldberg, 1964) this does not seem to be the only mechanism.
The mechanism of anaemia in the remaining patients was less certain, many showing disturbance of iron metabolism as is frequently seen in RA. An increase in plasma volume is commonly associated with enlargement of the spleen and probably contributes to anaemia in patients with Felty's syndrome (Blendis, Ansell, Lloyd-Jones, Hamilton, and Williams, 1970a) . In most patients the neutrophil count was lower than lymphocytes. Absolute lymphocytosis is claimed only to occur after splenectomy (de Gruchy, 1965) , but five of our patients had, early in the course of their disease, sufficient lymphocytes to keep the total white cell count within normal limits in the presence of neutropenia.
The variability of the manifestations of the syndrome make it difficult to assess prognosis in individual patients and the value of the treatment given. This may explain the conflicting reports of the effects of corticosteroids (Pengelly, 1966; Ruderman and others, 1968) and of splenectomy (Collier and Brush, 1966; Green and Fromke, 1966; Ruderman and others, 1968) . To make a more valid assessment we have divided our patients into three groups according to the severity of their disease.
As in other series the benefit of corticosteroid treatment was variable and generally unspectacular. One moderately affected patient appeared to have been cured by prednisone. The results in this patient and in one reported by Pengelly (1966) indicate that corticosteroid therapy may occasionally be successful. On the other hand the same dosage of prednisone produced only partial improvement in two out of six severely affected patients. Corticosteroids in small dosage did not have any significant beneficial effect on the haematological abnormality.
The rarity of dramatic benefit from steroid therapy in our series agrees with previous reports (Collier and Brush, 1966; Ruderman and others, 1968) and must be considered in the light of the spontaneous remissions in this series seen in two patients, albeit mildly affected, who never received corticosteroids and in one on a small constant dose.
The initial haematological response to splenectomy was as good in this series as has previously been described (de Gruchy, 1965; Collier and Brush, 1966; Ruderman and others, 1968) , and was associated with comparable clinical improvement.
There was less complete correlation between clinical and haematological status in the months after splenectomy. Only one patient achieved a complete permanent remission. Three patients maintained normal blood counts for more than 3 months but all continued to have infections which proved fatal in one. The blood count relapsed in four patients within 3 months of operation but only one of these has since had severe infections. This experience is very similar to that of Ruderman and others(1968) but is much less favourable than has been suggested in some previous reports in which the follow-up has been shorter (Green and Fromke, 1966; Hahn, Mayne, and Kiely, 1963) . Only three of the ten splenectomized patients in this series still have fully normal blood counts, 14i, 8j, and 6 years since operation respectively, and one of these went through a haematological relapse lasting 3 years from which she recovered spontaneously. However, even those who relapsed haematologically appear to have had a better chance of survival than before. Thus we believe that splenectomy remains the treatment of choice for patients with very severe infection.
The second indication for splenectomy is severe anaemia due either to sequestration of red cells and haemodilution (Blendis and others, 1970a) or to haemolysis when this is not oontrolled by small doses of steroids, and particularly when the spleen is the site of red cell destruction.
The third definite indication for splenectomy is severe haemorrhage associated with thrombocytopenia (Cudkowicz, 1956) . If, as in Case No. 9, haemorrhage is due to portal hypertension, this must be treated on its own merits.
The lack of correlation between infection and the blood count before and after operation in their patients led Ruderman and others (1968) to conclude that leucopenia alone was not an indication for splenectomy. Only one of our patients had a splenectomy for leucopenia without serious infection. The relapse in her blood count 4 months later and the development of recurrent chest infections 1I years after operation support this conclusion.
Furthermore, in our own cases, the similar lack of correlation between the level of the neutrophil count and the severity of infection (as indicated by differences in patients in groups I and II), and the lack of correlation between infection and the white cell count after splenectomy, all confirm the belief that neutropenia alone does not warrant splenectomy.
The pathological findings in the thirteen spleens from patients with Felty's syndrome, when compared with those from rheumatoid arthritis without Felty's syndrome, give further evidence of a specific pathological entity.
The severity of the changes in the follicular arteries could not be correlated with the age of the patient nor with the degree of splenic enlargement. In the absence of essential hypertension, these changes with endothelial hyperplasia and reticulin increase suggest that some degree of portal hypertension is a constant feature in Felty's syndrome (Ellman, Cudkowicz, and Elwood, 1955) .
The lymphoid follicles showed no constant changes, but the germinal follicles were generally inactive and hyaline material was present in the majority. This is in direct contrast to the view that striking hyperplasia of germinal centres in enlarged follicles is a characteristic feature of the spleen in Felty's syndrome (Gardner, 1965) .
Sinus cell hyperplasia accompanied by erythrophagocytosis was present in all the Felty spleens. Those in which erythrophagocytosis was most marked also displayed an excess of iron in macrophages and reticulum cells. These findings clearly indicate that excessive blood destruction within the spleen is a constant feature in Felty's syndrome, although this is not always sufficient to cause significant shortening of red cell survival. Whether neutrophil polymorphs are similarly destroyed is uncertain. Amyloid was not found in any of the specimens.
These consistent pathological abnormalities do not adequately explain the role of the spleen in Felty's syndrome. The presence of portal hypertension does not necessarily imply that this was the cause of the enlargement of the spleen, since some rise in portal blood pressure may be related to the increased blood flow characteristic of many types of splenic enlargement (Williams, Parsonson, Somers, and Hamilton, 1966; Blendis, Banks, Ramboer, and Williams, 1970b) .
Although an improvement in white cell count usually follows splenectomy, the frequency of subsequent relapse and occasional spontaneous remission later suggest that hypersplenism is only one factor in pathogenesis, probably not the most important. The lack of correlation between splenic size and the severity of the haematologioal abnormality is further evidence for this view. Our findings do not, however, indicate what other mechanism is primarily responsible.
It is never possible fully to exclude the effect of drugs on the bone marrow. The chief reasons for discounting their influence are the usual rapid recovery of bone marrow activity following the discontinuation of the drug (de Gruchy, 1965) , the absence of sustained splenic enlargement in a drug-induced neutropenia and the usual good early response to splenectomy in patients with Felty's syndrome. In the individual case it is always important to exclude other causes of bone marrow dysfunction, particularly deficiences of vitamin B12 or folic acid, and paroxysmal nocturnal haemoglobinuria which may present as mild haemolysis with leucopenia and thrombocytopenia without any macroscopic blood pigment in the urine. These conditions did not acoount for the haematological abnormalities in the cases reviewed. Summary 21 patients with Felty's syndrome have been reviewed. The six men were significantly older than the fifteen women at the onset of arthritis but developed the syndrome sooner. Nonarticular rheumatoid features were common, Sj0gren's syndrome being found in eleven of sixteen patients tested. Sera of all but two contained rheumatoid factor, and LE cell preparations and/or ANF tests were positive in fourteen patients. Absolute neutropenia was characteristic but its degree did not fully correlate with the severity of infections. All patients were anaemic, red cell survival being reduced in six of thirteen patients studied with excessive splenic destruction in three.
Haematological remission occurred in two patients spontaneously and in one of two on a small constant dose of prednisone. Of eight patients given 20 mg. prednisone per day or more, four had transient partial improvement and one apparent clinical cure.
Ten patients underwent splenectomy of whom two appear to have been cured. Two patients eventuaUy achieved normal blood counts after early relapses.
Eight patients have died including four following splenectomy.
The following histological features were found in all thirteen spleens examined:
(i) Hyaline change and endothelial hyperplasia of follicular arteries;
(ii) Sinuscellhyperplasiawitherythrophagocytosis; (iii) Plasma cell hyperplasia and extramedullary haemopoiesis in the cords; (iv) A birefringent particulate material in macophages and reticulum oells.
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